Prof. Dr. Gökşen İnanç İMAMOĞLU

1. The effect of switching from ribociclib to palbociclib due to toxicity in hormone receptor-positive, HER2-negative metastatic breast cancer: a real-world, multicenter, retrospective study

Oruç A., Deliktaş Onur İ., Uyar G. C., ŞAHİN T. K., Tünbekici S., ARSLAN KAPUCİ A., et al.

Scientific Reports , cilt.16, sa.1, 2026 (SCI-Expanded, Scopus)

2. Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

Seyyar M., Kalem A., Sali M., Karabuğa B., ŞAHİN T. K., Dişli A. K., et al.

Current Oncology , cilt.33, sa.6, 2026 (SCI-Expanded, Scopus)

3. Prognostic Significance of Dynamic Inflammatory Indices in Head and Neck Cancer During Induction Chemotherapy

Zeynelgil E., İMAMOĞLU G. İ., Dilli İ., Atak M. C., Yazilitaş D., Bayir Ö., et al.

Journal of Oncological Science , cilt.11, sa.3, ss.259-268, 2025 (Scopus, TRDizin)

4. De Novo Malignancies After Kidney Transplant: Where Do We Stand and Does the Head and Neck Region Require More Caution?

ULUSAL OKYAY G., AYERDEN EBİNÇ F., ATILGAN K. G., ALPER M., KARAMÜRSEL S., SELEN T., et al.

Experimental and Clinical Transplantation , cilt.23, sa.9, ss.604-611, 2025 (SCI-Expanded, Scopus)

5. Prognostic Value of Inflammatory Markers, CA 19-9, MELD Score, and ECOG in Stage 4 Gastric Cancer with Liver Metastases

Zeynelgil E., Gülcü S., Koçanoğlu A., Düzköprü Y., İMAMOĞLU G. İ., EREN T.

Acta Haematologica Oncologica Turcica , cilt.58, sa.2, ss.115-120, 2025 (Scopus, TRDizin)

6. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

Karacin C., Oksuzoglu B., Demirci A., Keskinkılıç M., Baytemür N. K., Yılmaz F., et al.

BMC Cancer , cilt.23, sa.1, 2023 (SCI-Expanded, Scopus)

7. Percutaneous ablation treatment in metastatic lung tumors: a single-center experience

Ergun O., BİRGİ E., Hekimoğlu A., Eraslan Ö., DURMAZ H., Karaçin C., et al.

Acta Radiologica , cilt.64, sa.8, ss.2416-2423, 2023 (SCI-Expanded, Scopus)

8. Second-line Chemotherapy in Advanced Gastric Cancer: Taxanes versus 5-FU-Based Treatment

Duzkopru Y., Cilbir E., İMAMOĞLU G. İ., Dogan O., EREN T.

Journal of the College of Physicians and Surgeons Pakistan , cilt.33, sa.7, ss.770-774, 2023 (SCI-Expanded, Scopus)

9. Outcomes of Chemotherapy plus Cetuximab as First-line Treatment in Patients with Metastatic, Recurrent, Unresectable Head and Neck Cancers: Real-life Data

Yazilitas D., ŞAHİNLİ H., Saylam G., İMAMOĞLU G. İ., Korkmaz M. H., Bayir O.

Journal of the College of Physicians and Surgeons Pakistan , cilt.33, sa.4, ss.469-473, 2023 (SCI-Expanded, Scopus)

10. Predictive and Prognostic Value of ABO Blood Group in Patients Using Immune Checkpoint Inhibitor for Advanced Renal Cell Carcinoma

Ergün Y., Uçar G., Aktürk Esen S., Bardakçi M., Kalkan Z., Urakçi Z., et al.

Journal of Oncological Science , cilt.8, sa.2, ss.100-106, 2022 (Scopus, TRDizin)

11. Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy

Karacin C., EREN T., Zeynelgil E., İMAMOĞLU G. İ., ALTINBAŞ M., KARADAĞ İ., et al.

Future Oncology , cilt.17, sa.33, ss.4447-4456, 2021 (SCI-Expanded, Scopus)

12. “Swords and Shields” against COVID-19 for patients with cancer at “clean” and “pandemic” hospitals: are we ready for the second wave?

Karacin C., Acar R., BAL Ö., EREN T., ŞENDUR M. A. N., Acikgoz Y., et al.

Supportive Care in Cancer , cilt.29, sa.8, ss.4587-4593, 2021 (SCI-Expanded, Scopus)

13. The impact of lymph node ratio on overall survival in patients with colorectal cancer

İMAMOĞLU G. İ., OĞUZ A., Cimen S., EREN T., Karacin C., Colak D., et al.

Journal of Cancer Research and Therapeutics , cilt.17, sa.4, ss.1069-1074, 2021 (SCI-Expanded, Scopus)

14. Factors associated with poor lymph node dissection of colon neoplasm Kolon kanseri cerrahisinde yetersiz lenf nodu Çıkarılması ile İlişkili risk faktörleri

Bostancı M. T., Yılmaz İ., Saydam M., Seki A., DEMİR P., İMAMOĞLU G. İ., et al.

Turkish Journal of Colorectal Disease , cilt.31, sa.4, ss.322-329, 2021 (Scopus, TRDizin)

15. The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study

Kaplan M. A., Oruc Z., Gumus M., Ozaydın S., ELKIRAN E. T., Dinc N. S., et al.

Journal of B.U.ON. , cilt.24, sa.3, ss.1081-1086, 2019 (SCI-Expanded, Scopus)

16. Investigation of the severity of depressive symptoms in cancer patients receiving chemotherapy

EREN T., İMAMOĞLU G. İ., Karacin C., Turker S., Cilbir E., ŞAHİNLİ H., et al.

Eastern Journal of Medicine , cilt.24, sa.4, ss.451-456, 2019 (Scopus, TRDizin)

17. Clinicopathological features of metaplastic breast carcinoma

HASDEMİR A. O., Tokgöz S., Koÿbasioglu F., Karabacak H., Yücesoy C., İMAMOĞLU G. İ.

Advances in Clinical and Experimental Medicine , cilt.27, sa.4, ss.509-513, 2018 (SCI-Expanded, Scopus)

18. Bilateral intra-abdominal testicular tumor: Case report

Sandikci F., ÇİMEN S., Cimen S. G., İMAMOĞLU G. İ., Han U., Kokurcan A., et al.

International Journal of Surgery Case Reports , cilt.49, ss.102-105, 2018 (Scopus)

19. Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study

Bilir C., YILDIZ İ., BİLİCİ A., Ucar M., Berk V., Yıldız Y., et al.

Cancer Investigation , cilt.35, sa.4, ss.248-255, 2017 (SCI-Expanded, Scopus)

Prof. Dr. Gökşen İnanç İMAMOĞLU

Yayınlar & Eserler